{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:47:57Z","timestamp":1778712477040,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ThromboGenics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41433-018-0230-0","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T08:02:50Z","timestamp":1539331370000},"page":"435-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Patient-reported prevalence of metamorphopsia and predictors of vision-related quality of life in vitreomacular traction: a prospective, multi-centre study"],"prefix":"10.1038","volume":"33","author":[{"name":"on behalf of the MeMo Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8682-4067","authenticated-orcid":false,"given":"Praveen J.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Hirnei\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Brazier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdalla","family":"Aly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-0330","authenticated-orcid":false,"given":"Benedicte","family":"Lescrauwaet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,12]]},"reference":[{"key":"230_CR1","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","volume":"120","author":"JS Duker","year":"2013","unstructured":"Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120:2611\u20139.","journal-title":"Ophthalmology"},{"key":"230_CR2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1097\/IAE.0b013e31829232fd","volume":"33","author":"TL Jackson","year":"2013","unstructured":"Jackson TL, Nicod E, Simpson A, Angelis A. Symptomatic vitreomacular adhesion. Retina. 2013;33:1503\u201311.","journal-title":"Retina"},{"key":"230_CR3","first-page":"809640","volume":"2015","author":"A Garc\u00eda-Layana","year":"2015","unstructured":"Garc\u00eda-Layana A, Garc\u00eda-Arum\u00ed J, Ruiz-Moreno JM, Arias-Barquet L, Cabrera-L\u00f3pez F, Figueroa MS. A review of current management of vitreomacular traction and macular hole. J Ophthalmol. 2015;2015:809640.","journal-title":"J Ophthalmol"},{"key":"230_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ajo.2009.11.022","volume":"149","author":"MW Johnson","year":"2010","unstructured":"Johnson MW. Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol. 2010;149:371\u20131.","journal-title":"Am J Ophthalmol"},{"key":"230_CR5","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1136\/bjo.86.8.902","volume":"86","author":"A Gandorfer","year":"2002","unstructured":"Gandorfer A, Rohleder M, Kampik A. Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol. 2002;86:902\u20139.","journal-title":"Br J Ophthalmol"},{"key":"230_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/eye.2015.171","volume":"30","author":"G Lina","year":"2016","unstructured":"Lina G, Xuemin Q, Qinmei W, Lijun S. Vision-related quality of life, metamorphopsia, and stereopsis after successful surgery for rhegmatogenous retinal detachment. Eye. 2016;30:40\u20135.","journal-title":"Eye"},{"key":"230_CR7","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1136\/bjo.2008.155440","volume":"93","author":"S Fukuda","year":"2009","unstructured":"Fukuda S, Okamoto F, Yuasa M, Kunikata T, Okamoto Y, Hiraoka T, et al. Vision-related quality of life and visual function in patients undergoing vitrectomy, gas tamponade and cataract surgery for macular hole. Br J Ophthalmol. 2009;93:1595\u20139.","journal-title":"Br J Ophthalmol"},{"key":"230_CR8","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1001\/archneur.55.10.1362","volume":"55","author":"MAJ Put van de","year":"1998","unstructured":"van de Put MAJ, Vehof J, Hooymans JMM, Los LI. Postoperative metamorphopsia in macula-off rhegmatogenous retinal detachment: associations with visual function, vision related quality of life, and optical coherence tomography findings. Arch Neurol. 1998;55:1362\u20138.","journal-title":"Arch Neurol"},{"key":"230_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10384-014-0323-7","volume":"58","author":"Y Okamoto","year":"2014","unstructured":"Okamoto Y, Okamoto F, Hiraoka T, Oshika T. Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy. Jpn J Ophthalmol. 2014;58:369\u201374.","journal-title":"Jpn J Ophthalmol"},{"key":"230_CR10","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1167\/iovs.11-9153","volume":"53","author":"Y Matsuoka","year":"2012","unstructured":"Matsuoka Y, Tanito M, Takai Y, Koyama Y, Nonoyama S, Ohira A. Visual function and vision-related quality of life after vitrectomy for epiretinal membranes: a 12-month follow-up study. Invest Ophthalmol Vis Sci. 2012;53:3054\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"230_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1167\/iovs.09-3992","volume":"51","author":"F Okamoto","year":"2010","unstructured":"Okamoto F, Okamoto Y, Fukuda S, Hiraoka T, Oshika T. Vision-related quality of life and visual function after vitrectomy for various vitreoretinal disorders. Invest Ophthalmol Vis Sci Assoc Res Vision Ophthalmol. 2010;51:744\u201351.","journal-title":"Invest Ophthalmol Vis Sci Assoc Res Vision Ophthalmol"},{"key":"230_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ajo.2008.11.018","volume":"147","author":"F Okamoto","year":"2009","unstructured":"Okamoto F, Okamoto Y, Hiraoka T, Oshika T. Effect of vitrectomy for epiretinal membrane on visual function and vision-related quality of life. Am J Ophthalmol. 2009;147:869\u201374\u2013874.e1. \n                    http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=19200531&retmode=ref&cmd=prlinks\n                    \n                  .","journal-title":"Am J Ophthalmol"},{"key":"230_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/bjo.2005.085142","volume":"90","author":"SMS Ghazi-Nouri","year":"2006","unstructured":"Ghazi-Nouri SMS, Tranos PG, Rubin GS, Adams ZC, Charteris DG. Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery. Br J Ophthalmol. 2006;90:559\u201362.","journal-title":"Br J Ophthalmol"},{"key":"230_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000441033","volume":"55","author":"E Midena","year":"2015","unstructured":"Midena E, Vujosevic S. Metamorphopsia: an overlooked visual symptom. Ophthalmic Res Karger Publ. 2015;55:26\u201336.","journal-title":"Ophthalmic Res Karger Publ"},{"key":"230_CR15","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1111\/aos.12795","volume":"94","author":"JW Kim","year":"2016","unstructured":"Kim JW, Kim YT. Clinical application of 3D display device in ophthalmology: measurement of metamorphopsia. Acta Ophthalmol. 2016;94:e54\u20138.","journal-title":"Acta Ophthalmol"},{"key":"230_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1167\/iovs.09-3535","volume":"52","author":"E Arimura","year":"2011","unstructured":"Arimura E, Matsumoto C, Nomoto H, Hashimoto S, Takada S, Okuyama S, et al. Correlations between M-CHARTS and PHP findings and subjective perception of metamorphopsia in patients with macular diseases. Invest Ophthalmol Vis Sci. 2011;52:128\u201335.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"230_CR17","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM. Development of the 25-list-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol Am Med Assoc. 2001;119:1050\u20138.","journal-title":"Arch Ophthalmol Am Med Assoc"},{"key":"230_CR18","unstructured":"RAND C. The National Eye Institute 25-item Visual Function Questionnaire (VFQ-25). 2000:1\u201315. \n                    https:\/\/www.rand.org\/health\/surveys_tools\/vfq.html\n                    \n                  . Accessed June 30, 2017."},{"key":"230_CR19","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360\u20133.","journal-title":"Fam Med"},{"key":"230_CR20","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.ophtha.2016.06.043","volume":"123","author":"PU Dugel","year":"2016","unstructured":"Dugel PU, Tolentino M, Feiner L, Kozma P, Leroy A. Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial. Ophthalmology. 2016;123:2232\u201347.","journal-title":"Ophthalmology"},{"key":"230_CR21","unstructured":"OASIS Clinical Study Report, Data om File, ThromboGenics."},{"key":"230_CR22","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.ophtha.2012.02.029","volume":"119","author":"L Patty","year":"2012","unstructured":"Patty L, Wu C, Torres M, Azen S, Varma R, Los Angeles Latino Eye Study Group. Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study. Ophthalmology. 2012;119:1725\u201330.","journal-title":"Ophthalmology"},{"key":"230_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jcjo.2016.03.011","volume":"51","author":"M Popovic","year":"2016","unstructured":"Popovic M, Chaudhary V, McKay BR, Moinul P, Mohaghagh M, Beattie A, et al. Discrepancies in physician\u2013patient agreement in reporting ocular history. Can J Ophthalmol. 2016;51:378\u201381.","journal-title":"Can J Ophthalmol"},{"key":"230_CR24","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/jamaophthalmol.2015.1746","volume":"133","author":"R Varma","year":"2015","unstructured":"Varma R, Haller JA, Kaiser PK. Improvement in patient-reported visual function after ocriplasmin for vitreomacular adhesion: results of the microplasmin for intravitreous injection-traction release without surgical treatment (MIVI-TRUST) trials. JAMA Ophthalmol. 2015;133:997\u20131004.","journal-title":"JAMA Ophthalmol"},{"key":"230_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1056\/NEJMoa1110823","volume":"367","author":"P Stalmans","year":"2012","unstructured":"Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, et al. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012;367:606\u201315.","journal-title":"N Engl J Med"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0230-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0230-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0230-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:05:26Z","timestamp":1684616726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-018-0230-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,12]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1038\/s41433-018-0230-0","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,12]]},"assertion":[{"value":"15 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Praveen J. Patel reports grants (to institution) from Oxurion NV during the conduct of the study. Dr. Christoph Hirnei\u00df, Prof. John Brazier report consultation fees from Oxurion NV during the conduct of the study. Abdalla Aly reports employment by Pharmerit International that received consultation fees from Oxurion NV for the analysis of the data. Benedicte Lescrauwaet reports consultation fees from Oxurion NV during the conduct of the study and outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}